We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
27 Nov 20
BioInvent will receive up to 3.52m for the development, scale-up, supply of material for toxicological studies and clinical…
23 Nov 20
The research collaboration will leverage ARCUS genome editing technology, and initially include three gene targets
02 Nov 20
Collaboration with GeneQuantum follows Samsung Biologics' recent partnership with China-based biotech company APRINOIA Therapeutics
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
29 Oct 20
Molecular Partners will receive an upfront payment of $65.97m, and an additional payment of $164.93m after the option…
28 Oct 20
CStone’s licencing agreement enables EQRx to develop and commercialise the two late-stage immuno-oncology drugs outside of Greater China
09 Oct 20
Takeda to make an upfront payment of $300m and up to $740m to Arrowhead as potential milestone payments
01 Oct 20
VLP Therapeutics’ Covid-19 vaccine is said to be a self-amplifying RNA vaccine that leverages lipid nanoparticle formulation, a…
22 Sep 20
Samsung Biologics will offer large-scale commercial manufacturing in its Plant 3 along with drug product to support AstraZeneca's…
21 Sep 20
The potential Covid-19 vaccine candidate leverages Sanofi’s recombinant protein-based technology and GSK’s pandemic adjuvant technology
17 Sep 20
RDIF will supply Dr. Reddy's with 100 million doses of potential Covid-19 vaccine Sputnik V, upon receiving the…